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Patrick M. Honore* and Herbert D. SpapenSee related research by Doenyas-Barak et al., http://www.ccforum.com/content/20/1/10We read with interest the recent paper by Doenyas-Barak
et al. [1] comparing the prognosis of extremely elevated
plasma lactate levels between metformin (MET)-treated
and MET-naive patients with septic shock. The most re-
markable finding was a highly significant lower in-hospital
mortality (56.8 vs. 88.1 %, p < 0.0001) in MET users despite
a more explicit risk profile (diabetes, older age) and greater
baseline disease severity (higher incidences of cardiovascu-
lar disease, acute kidney injury, and underlying malignancy)
[1]. The authors briefly elaborate on this unexpected sur-
vival benefit by pointing out some potential protective
MET-related anti-inflammatory, anti-thrombotic, and cellu-
lar effects. However, we believe that the observed difference
in mortality rate is most likely due to the more frequent
use of renal replacement therapy (RRT) in the MET-treated
population (38.6 vs. 21.2 %, p = 0.13).
Whereas initiation of RRT is generally stigmatized as a
bad prognostic sign in the critically ill, it might be life-
saving in MET users presenting with septic shock and
severe lactic acidosis. A protective effect of RRT has
already been suggested by Peters et al. [2] who found that,
despite higher illness severity, the mortality rate in patients
with MET-associated lactic acidosis treated with intermit-
tent hemodialysis (IHD) was no different to that of non-* Correspondence: Patrick.Honore@az.vub.ac.be
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centrations >20 mmol/L or pH ≤7.0, in case of shock or
decreased level of consciousness, and when standard sup-
portive measures fail [3]. Early IHD is the preferred mode
of treatment. For several reasons, however, continuous
RRT (CRRT) is thought to be physiologically more appro-
priate than IHD. First, because of its low molecular weight
and minimal protein binding, MET is equally (highly) elim-
inated by ultrafiltration (convection) as compared to dialy-
sis (diffusion). Second, and more importantly, its large
volume of distribution within a two-compartment pharma-
cokinetic model implies that MET may be more effectively
cleared by prolonged RRT. This was corroborated by Keller
et al. [4] who recently showed a dramatic reduction of
metabolic acidosis and decrease of MET plasma con-
centrations within the first 24 h after initiating CRRT in
patients with MET-induced lactic acidosis, followed by
normalization on the second day in all subjects. Finally,
consensus exists that CRRT is better tolerated in he-
modynamically unstable patients, and is also associated
with a higher rate of renal recovery compared with IHD
[5]. This will certainly benefit septic MET-imbedded pa-
tients who often present with catecholamine-dependent
septic shock and faltering or lost kidney function.Authors’ response
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the low molecular weight of lactate (90 Da, which is very
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with severe lactic acidosis are good candidates for RRT
[6]. However, lactate itself is not toxic, and data regardingis article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Honore and Spapen Critical Care  (2016) 20:127 Page 2 of 2the yield of RRT in patients with severe lactic acidosis are
scarce. In MALA, RRT may contribute to both lactate and
metformin removal. Unfortunately, data regarding the ef-
fect of RRT in the setting of MALA are also limited, being
based mostly on observational studies or very small trials.
In one of them, although improved prognosis of patients
requiring RRT was not actually demonstrated, the authors
believed that the prognosis might have been worse [2].
However, even though reliable data comparing RRT given
"prophylactically" at an early stage vs. RRT given according
to classical clinical indications (as determined by the treat-
ing nephrologist) do not exist, some experts still strongly
recommend the earliest possible initiation of RRT [3].
Following the letter of Drs. Honore and Spapen, we per-
formed further statistical analysis of our study cohort to
evaluate whether more frequent RRT in the metformin-
treated group may explain the survival benefit. Multivari-
ate Cox regression analyses were redone for the evaluation
of adjusted hazard ratios (HRs) of metformin treatment,
with RRT added to the confounders (in addition to age,
gender, diabetes, hypertension, ischemic heart disease,
cerebrovascular attack, malignancy, creatinine, and Acute
Physiology and Chronic Health Evaluation (APACHE) II
score). The effect of the hazard related to metformin treat-
ment remained statistically significant (HR = 0.18; 95 %
confidence interval 0.03–0.92; p = 0.04). Thus, the use of
RRT does not appear to explain the protective effect of
metformin in the current cohort of patients [1].
Another unresolved issue relates to the preferred RRT
modality, and to whether CRRT may be physiologically
more appropriate than IHD for MALA patients. CRRT
is the preferred modality in patients who are hemodyna-
mically unstable and cannot tolerate IHD due to blood
pressure fluctuations. However, for other MALA patients,
hemodialysis may be the preferred approach since metfor-
min clearance is less effective under the convective treat-
ment used in CRRT [7]. Unfortunately, the size of our
study population was not sufficient to address the preferred
RRT modality for MALA patients.
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